Publicação
Baby wish comes true with the help of Ivf - long term growth, amid short term challenges
| datacite.subject.fos | Ciências Sociais::Economia e Gestão | pt_PT |
| dc.contributor.advisor | André, Rosário | |
| dc.contributor.author | Nicolai, Jonas | |
| dc.date.accessioned | 2023-09-01T14:45:09Z | |
| dc.date.available | 2023-09-01T14:45:09Z | |
| dc.date.issued | 2023-01-17 | |
| dc.date.submitted | 2022-12-16 | |
| dc.description.abstract | This equity research report is about the company Vitrolife. We anticipate that increasing demand for IVF due to increasing maternal age and increasing infertility rates will drive Vitrolife’s long-term growth. A setback could be the APAC region's competitive environment due to its competitors' acquisitions. We see a value driver in Vitrolife’s acquisition of genetic testing service provider Igenomix, positively affecting Vitrolife sales growth in the future. According to this analysis, we set a price target for Vitrolife of SEK233.51 in 2023 and hence give a buy recommendation with an expected total return of 21.34%. | pt_PT |
| dc.identifier.tid | 203313461 | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10362/157167 | |
| dc.language.iso | eng | pt_PT |
| dc.relation | UID/ECO/00124/2013 | pt_PT |
| dc.subject | Vitrolife | pt_PT |
| dc.subject | Ivf | pt_PT |
| dc.subject | Valuation | pt_PT |
| dc.title | Baby wish comes true with the help of Ivf - long term growth, amid short term challenges | pt_PT |
| dc.type | master thesis | |
| dspace.entity.type | Publication | |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | masterThesis | pt_PT |
| thesis.degree.name | A Work Project, presented as part of the requirements for the Award of a Masters Degree in Finance from the NOVA – School of Business and Economics | pt_PT |